Neutrophil response to poly( N -vinylpyrrolidone) nanogel: changes in protein profile and reactive oxygen species (ROS) production

Read full text
Authors: Isabelle Souza Luz, Liudy García Hernández, Katyelle Botelho, Scarlat G. R. dos Anjos, Adrián Ges, Manuel Rapado‐Paneque, Wagner Fontes
Cited by: 0
References: 59

Abstract

Abstract Upon arrival at the site of inflammation, neutrophils can unleash an arsenal of biotoxic agents, including reactive oxygen species (ROS) and antimicrobial proteins. Such a powerful response is essential to defense and survival but is also associated with host damage. Despite their pivotal role, little is known about the effects of synthetic particles on neutrophil responses. It is crucial to comprehend their impact on innate immunity, as nanoparticles can potentially emerge as either a risk factor or beneficial contributor by modulating inflammation. Here, we study the influence of 30 nm poly( N -vinylpyrrolidone) (PVP) nanogels (NG) on human neutrophils through proteomic analysis. Neutrophils were isolated from human blood and incubated with NG. The proteomic analysis identified 65 proteins with differential abundance profile between the control and NG groups. NG caused upregulation of proteins associated with antioxidant activity, indicating the presence of ROS, which was confirmed by the nitroblue tetrazolium assay. Cytosolic granule proteins related to vesicle transport and actin-binding cytoskeleton proteins were down-regulated. Such changes in the proteome profile after NG incubation indicate neutrophil activation by modulation of classical functions such as ROS production and degranulation. These findings have implications for the use of NG as drug carriers and modulators of neutrophil functions.

Fields of Study & Subjects

Neutrophil Myeloperoxidase and Oxidative Mechanisms Nanoparticle-Based Drug Delivery Immunotoxicology and immune responses

Publication details

Journal / source
Advances in Natural Sciences Nanoscience and Nanotechnology
Volume
17
Issue
1
Pages
015016–015016
Publication date
27 January 2026